Tag: Rogerio Vivaldi

Lilly to transform chronic disease management with Sigilon Therapeutics acquisition

businessnewstoday- June 30, 2023

Pharmaceutical giant Eli Lilly and Company (Lilly) has announced its definitive agreement to acquire Nasdaq-listed biopharma innovator Sigilon Therapeutics, in a move set to significantly ... Read More